# |
|
Family |
MCID |
Name |
MIFTS |
Score |
1 |
|
|
CNG034 |
Congestive Heart Failure |
69 |
0.164 |
|
2 |
|
c
|
HYP595 |
Hypertension, Essential |
84 |
0.148 |
|
3 |
|
c
|
ACT075 |
Acute Myocardial Infarction |
57 |
0.108 |
|
4 |
|
c
|
DLT002 |
Dilated Cardiomyopathy |
79 |
0.100 |
|
5 |
|
|
ANG054 |
Angina Pectoris |
66 |
0.100 |
|
6 |
|
c
|
ATR087 |
Atrial Standstill 1 |
75 |
0.082 |
|
7 |
|
P
|
DBT026 |
Diabetes Mellitus, Noninsulin-Dependent |
90 |
0.071 |
|
8 |
|
P
|
KDN018 |
Kidney Disease |
72 |
0.071 |
|
9 |
|
P
|
DBT009 |
Diabetes Mellitus |
64 |
0.071 |
|
10 |
|
c
|
MTR018 |
Maturity-Onset Diabetes of the Young, Type 1 |
62 |
0.071 |
|
11 |
|
P
|
ANG015 |
Angioedema |
57 |
0.071 |
|
12 |
|
c
|
MCR113 |
Microvascular Complications of Diabetes 3 |
52 |
0.071 |
|
13 |
|
P
|
RNV001 |
Renovascular Hypertension |
48 |
0.071 |
|
14 |
|
c
|
MCR120 |
Microvascular Complications of Diabetes 7 |
47 |
0.071 |
|
15 |
|
c
|
MCR130 |
Microvascular Complications of Diabetes 6 |
41 |
0.071 |
|
16 |
|
c
|
MCR133 |
Microvascular Complications of Diabetes 4 |
41 |
0.071 |
|
17 |
|
|
SNG003 |
Single Ventricular Heart |
30 |
0.071 |
|
18 |
|
P
|
RHM011 |
Rheumatoid Arthritis |
80 |
0.058 |
|
19 |
|
P
|
HRT032 |
Heart Disease |
75 |
0.058 |
|
20 |
|
c
|
THR092 |
Thrombophilia Due to Thrombin Defect |
73 |
0.058 |
|
21 |
|
P
|
CNR004 |
Cone-Rod Dystrophy 2 |
73 |
0.058 |
|
22 |
|
P
|
HYP724 |
Hyperlipoproteinemia, Type Iii |
73 |
0.058 |
|
23 |
|
P
|
NRB001 |
Neuroblastoma |
72 |
0.058 |
|
24 |
|
c
|
VNT034 |
Ventricular Fibrillation, Paroxysmal Familial, 1 |
67 |
0.058 |
|
25 |
|
P
|
MCR115 |
Microvascular Complications of Diabetes 5 |
66 |
0.058 |
|
26 |
|
c
|
MCR129 |
Microvascular Complications of Diabetes 1 |
66 |
0.058 |
|
27 |
|
|
ATH013 |
Atherosclerosis Susceptibility |
65 |
0.058 |
|
28 |
|
P
|
BLD124 |
Bleeding Disorder, Platelet-Type, 11 |
63 |
0.058 |
|
29 |
|
|
LPP008 |
Lipoprotein Quantitative Trait Locus |
62 |
0.058 |
|
30 |
|
|
TXC005 |
Toxic Shock Syndrome |
62 |
0.058 |
|
31 |
|
|
SPN186 |
Spinal Cord Injury |
60 |
0.058 |
|
32 |
|
P
|
VNT002 |
Ventricular Septal Defect |
60 |
0.058 |
|
33 |
|
|
PRT058 |
Pure Autonomic Failure |
59 |
0.058 |
|
34 |
|
|
ISC004 |
Ischemia |
58 |
0.058 |
|
35 |
|
|
HMR039 |
Hemorrhage, Intracerebral |
57 |
0.058 |
|
36 |
|
|
PLM010 |
Pulmonary Edema |
54 |
0.058 |
|
37 |
|
|
ART140 |
Arteries, Anomalies of |
52 |
0.058 |
|
38 |
|
|
HRT011 |
Heart Septal Defect |
50 |
0.058 |
|
39 |
|
|
QDR001 |
Quadriplegia |
48 |
0.058 |
|
40 |
|
c
|
MTR002 |
Mitral Valve Insufficiency |
48 |
0.058 |
|
41 |
|
c
|
MLG069 |
Malignant Hypertension |
47 |
0.058 |
|
42 |
|
|
ACT003 |
Acute Kidney Tubular Necrosis |
45 |
0.058 |
|
43 |
|
c
|
ORT011 |
Orthostatic Hypotension 1 |
44 |
0.058 |
|
44 |
|
c
|
MCR112 |
Microvascular Complications of Diabetes 2 |
41 |
0.058 |
|
45 |
|
|
C1N001 |
C1 Inhibitor Deficiency |
39 |
0.058 |
|
46 |
|
|
48X005 |
48,xyyy |
39 |
0.058 |
|
47 |
|
P
|
LNG032 |
Lung Cancer |
98 |
0.041 |
|
48 |
|
P
|
BRS047 |
Breast Cancer |
97 |
0.041 |
|
49 |
|
c
|
SYS001 |
Systemic Lupus Erythematosus |
86 |
0.041 |
|
50 |
|
|
MYL069 |
Myeloma, Multiple |
85 |
0.041 |
|
51 |
|
c
|
LKM061 |
Leukemia, Acute Myeloid |
84 |
0.041 |
|
52 |
|
P
|
PRT133 |
Proteasome-Associated Autoinflammatory Syndrome 1 |
81 |
0.041 |
|
53 |
|
|
STR067 |
Stroke, Ischemic |
81 |
0.041 |
|
54 |
|
|
INS024 |
Insulin-Like Growth Factor I |
79 |
0.041 |
|
55 |
|
P
|
BDY004 |
Body Mass Index Quantitative Trait Locus 11 |
76 |
0.041 |
|
56 |
|
P
|
RSP003 |
Respiratory Failure |
74 |
0.041 |
|
57 |
|
|
SCK003 |
Sickle Cell Anemia |
74 |
0.041 |
|
58 |
|
|
LPT014 |
Leptin Deficiency or Dysfunction |
74 |
0.041 |
|
59 |
|
|
MSC157 |
Muscular Dystrophy, Duchenne Type |
72 |
0.041 |
|
60 |
|
P
|
FML011 |
Familial Adenomatous Polyposis |
72 |
0.041 |
|
61 |
|
|
FBR012 |
Fabry Disease |
72 |
0.041 |
|
62 |
|
|
PRP027 |
Peripheral Vascular Disease |
71 |
0.041 |
|
63 |
|
P
|
MYC007 |
Myocardial Infarction |
70 |
0.041 |
|
64 |
|
|
DFC004 |
Deficiency Anemia |
70 |
0.041 |
|
65 |
|
|
DWN001 |
Down Syndrome |
70 |
0.041 |
|
66 |
|
P
|
HYP061 |
Hypertrophic Cardiomyopathy |
70 |
0.041 |
|
67 |
|
|
ADL002 |
Adult Syndrome |
70 |
0.041 |
|
68 |
|
c
|
NRD033 |
Neurodegeneration with Brain Iron Accumulation 2a |
69 |
0.041 |
|
69 |
|
P
|
MLN008 |
Melanoma |
69 |
0.041 |
|
70 |
|
P
|
ART022 |
Arthritis |
69 |
0.041 |
|
71 |
|
c
|
PRG042 |
Progressive Familial Heart Block, Type Ia |
69 |
0.041 |
|
72 |
|
P
|
LKM062 |
Leukemia, Acute Lymphoblastic |
69 |
0.041 |
|
73 |
|
P
|
LYM118 |
Lymphoma |
68 |
0.041 |
|
74 |
|
P
|
PNM007 |
Pneumonia |
68 |
0.041 |
|
75 |
|
P
|
SYS005 |
Systemic Scleroderma |
68 |
0.041 |
|
76 |
|
P
|
LKM002 |
Leukemia |
68 |
0.041 |
|
77 |
|
|
SKN019 |
Skin Melanoma |
68 |
0.041 |
|
78 |
|
c
|
CRD086 |
Cardiomyopathy, Familial Hypertrophic, 1 |
68 |
0.041 |
|
79 |
|
P
|
ALP004 |
Alport Syndrome |
68 |
0.041 |
|
80 |
|
P
|
HPT021 |
Hepatitis |
67 |
0.041 |
|
81 |
|
|
CRB039 |
Cerebrovascular Disease |
67 |
0.041 |
|
82 |
|
P
|
TRN020 |
Turner Syndrome |
67 |
0.041 |
|
83 |
|
P
|
PLM037 |
Pulmonary Hypertension |
67 |
0.041 |
|
84 |
|
c
|
RHB024 |
Rhabdomyosarcoma 2 |
67 |
0.041 |
|
85 |
|
|
ANM044 |
Anemia, X-Linked, with or Without Neutropenia and/or Platelet Abnormalities |
67 |
0.041 |
|
86 |
|
|
ALC007 |
Alcohol Dependence |
66 |
0.041 |
|
87 |
|
P
|
DMN002 |
Dementia |
66 |
0.041 |
|
88 |
|
P
|
MSC005 |
Muscular Dystrophy |
66 |
0.041 |
|
89 |
|
P
|
ATR011 |
Atrial Fibrillation |
66 |
0.041 |
|
90 |
|
|
CHG001 |
Chagas Disease |
66 |
0.041 |
|
91 |
|
|
KHL003 |
Kohlschutter-Tonz Syndrome |
65 |
0.041 |
|
92 |
|
c
|
FML001 |
Familial Atrial Fibrillation |
65 |
0.041 |
|
93 |
|
|
MSM014 |
Mismatch Repair Cancer Syndrome |
65 |
0.041 |
|
94 |
|
|
BRR014 |
Barrett Esophagus |
65 |
0.041 |
|
95 |
|
c
|
DBT099 |
Diabetes Mellitus, Type I |
65 |
0.041 |
|
96 |
|
|
GST106 |
Gastrointestinal Ulceration, Recurrent, with Dysfunctional Platelets |
64 |
0.041 |
|
97 |
|
P
|
ABD014 |
Abdominal Obesity-Metabolic Syndrome 1 |
64 |
0.041 |
|
98 |
|
|
MSC007 |
Muscle Hypertrophy |
64 |
0.041 |
|
99 |
|
P
|
ADN016 |
Adenocarcinoma |
64 |
0.041 |
|
100 |
|
P
|
GLM045 |
Glioma |
63 |
0.041 |
|
101 |
|
c
|
PRC016 |
Pre-Eclampsia |
63 |
0.041 |
|
102 |
|
P
|
VSC007 |
Vascular Disease |
63 |
0.041 |
|
103 |
|
|
MSC152 |
Muscular Dystrophy, Becker Type |
63 |
0.041 |
|
104 |
|
c
|
SVR001 |
Severe Acute Respiratory Syndrome |
62 |
0.041 |
|
105 |
|
|
ALL026 |
Allergic Hypersensitivity Disease |
62 |
0.041 |
|
106 |
|
|
LVR012 |
Liver Cirrhosis |
62 |
0.041 |
|
107 |
|
|
NTR005 |
Nutritional Deficiency Disease |
62 |
0.041 |
|
108 |
|
|
HYP066 |
Hyperglycemia |
61 |
0.041 |
|
109 |
|
|
DRM006 |
Dermatitis |
61 |
0.041 |
|
110 |
|
P
|
PNC044 |
Pancreatitis |
61 |
0.041 |
|
111 |
|
P
|
LPS004 |
Lupus Erythematosus |
61 |
0.041 |
|
112 |
|
P
|
MYL006 |
Myeloid Leukemia |
60 |
0.041 |
|
113 |
|
c
|
ACT027 |
Acute Pancreatitis |
60 |
0.041 |
|
114 |
|
c
|
ACT071 |
Acute Kidney Failure |
60 |
0.041 |
|
115 |
|
|
PRT013 |
Portal Hypertension |
59 |
0.041 |
|
116 |
|
c
|
PSD114 |
Pseudohypoaldosteronism, Type I, Autosomal Recessive |
59 |
0.041 |
|
117 |
|
P
|
BRN022 |
Bronchiectasis |
59 |
0.041 |
|
118 |
|
|
HYD058 |
Hydrops, Lactic Acidosis, and Sideroblastic Anemia |
59 |
0.041 |
|
119 |
|
|
ANR040 |
Aneurysm |
59 |
0.041 |
|
120 |
|
|
PPT005 |
Peptic Ulcer Disease |
59 |
0.041 |
|
121 |
|
|
CRD132 |
Cardiac Conduction Defect |
58 |
0.041 |
|
122 |
|
P
|
ALC033 |
Alcohol Use Disorder |
58 |
0.041 |
|
123 |
|
|
INT324 |
Intrauterine Growth Retardation, Metaphyseal Dysplasia, Adrenal Hypoplasia Congenita, and Genital Anomalies |
58 |
0.041 |
|
124 |
|
P
|
GLM007 |
Glomerulonephritis |
57 |
0.041 |
|
125 |
|
P
|
EXN002 |
Exanthem |
57 |
0.041 |
|
|
127 |
|
|
MLT161 |
Multinucleated Neurons, Anhydramnios, Renal Dysplasia, Cerebellar Hypoplasia, and Hydranencephaly |
57 |
0.041 |
|
128 |
|
P
|
CRD246 |
Cardiovascular System Disease |
57 |
0.041 |
|
129 |
|
|
VSC002 |
Vascular Dementia |
57 |
0.041 |
|
130 |
|
|
HMT008 |
Hematuria, Benign Familial |
56 |
0.041 |
|
131 |
|
c
|
INT072 |
Intestinal Pseudo-Obstruction |
56 |
0.041 |
|
132 |
|
P
|
NRP001 |
Neuropathy |
56 |
0.041 |
|
133 |
|
|
PSD063 |
Pseudohyperkalemia, Familial, 2, Due to Red Cell Leak |
56 |
0.041 |
|
134 |
|
|
AGN016 |
Aging |
56 |
0.041 |
|
135 |
|
|
ATR057 |
Atrioventricular Block |
55 |
0.041 |
|
136 |
|
c
|
FML035 |
Familial Hyperlipidemia |
55 |
0.041 |
|
137 |
|
c
|
PRG126 |
Progressive Familial Heart Block |
55 |
0.041 |
|
138 |
|
P
|
ATR001 |
Atrioventricular Septal Defect |
55 |
0.041 |
|
139 |
|
|
MMB001 |
Membranoproliferative Glomerulonephritis |
55 |
0.041 |
|
140 |
|
|
INT007 |
Intermediate Coronary Syndrome |
55 |
0.041 |
|
141 |
|
c
|
PRG043 |
Progressive Familial Heart Block, Type Ib |
54 |
0.041 |
|
142 |
|
|
GLC003 |
Glucose Intolerance |
54 |
0.041 |
|
143 |
|
P
|
CNT116 |
Contractures, Pterygia, and Spondylocarpotarsal Fusion Syndrome 1a |
54 |
0.041 |
|
144 |
|
|
AMN001 |
Amenorrhea |
54 |
0.041 |
|
145 |
|
|
LYM040 |
Lymphoblastic Lymphoma |
54 |
0.041 |
|
146 |
|
|
HRT012 |
Heart Valve Disease |
53 |
0.041 |
|
147 |
|
P
|
HMC002 |
Homocystinuria |
53 |
0.041 |
|
148 |
|
|
PRP080 |
Peripheral Artery Disease |
53 |
0.041 |
|
149 |
|
c
|
MLN055 |
Melanoma, Cutaneous Malignant 10 |
52 |
0.041 |
|
150 |
|
c
|
CRS016 |
Crisponi/cold-Induced Sweating Syndrome 1 |
52 |
0.041 |
|
151 |
|
|
ACR041 |
Acromelic Frontonasal Dysostosis |
52 |
0.041 |
|
152 |
|
c
|
BDY021 |
Body Mass Index Quantitative Trait Locus 20 |
52 |
0.041 |
|
153 |
|
P
|
BRT004 |
Bartter Disease |
52 |
0.041 |
|
154 |
|
|
IMP005 |
Impotence |
52 |
0.041 |
|
155 |
|
c
|
BDY020 |
Body Mass Index Quantitative Trait Locus 19 |
52 |
0.041 |
|
156 |
|
|
PNG002 |
Pain Agnosia |
51 |
0.041 |
|
157 |
|
|
OCL069 |
Ocular Motor Apraxia |
51 |
0.041 |
|
158 |
|
|
PLS009 |
Plasma Cell Neoplasm |
51 |
0.041 |
|
159 |
|
|
END086 |
End Stage Renal Disease |
51 |
0.041 |
|
160 |
|
|
ALP041 |
Alopecia, Neurologic Defects, and Endocrinopathy Syndrome |
51 |
0.041 |
|
161 |
|
P
|
ECL001 |
Eclampsia |
50 |
0.041 |
|
162 |
|
P
|
SCK005 |
Sickle Cell Disease |
50 |
0.041 |
|
163 |
|
P
|
IGN003 |
Iga Nephropathy 1 |
49 |
0.041 |
|
164 |
|
|
SYS003 |
Systolic Heart Failure |
49 |
0.041 |
|
165 |
|
|
HYP006 |
Hypertensive Heart Disease |
49 |
0.041 |
|
166 |
|
|
LFT001 |
Left Bundle Branch Hemiblock |
49 |
0.041 |
|
167 |
|
|
END021 |
Endomyocardial Fibrosis |
49 |
0.041 |
|
168 |
|
|
CCN002 |
Cocaine Abuse |
49 |
0.041 |
|
169 |
|
|
URM002 |
Uremia |
49 |
0.041 |
|
170 |
|
|
RGH001 |
Right Bundle Branch Block |
48 |
0.041 |
|
171 |
|
|
IGG001 |
Iga Glomerulonephritis |
48 |
0.041 |
|
172 |
|
|
LPT006 |
Leptin Receptor Deficiency |
48 |
0.041 |
|
173 |
|
c
|
BDY005 |
Body Mass Index Quantitative Trait Locus 9 |
48 |
0.041 |
|
174 |
|
|
MCR209 |
Microcephaly, Epilepsy, and Diabetes Syndrome |
47 |
0.041 |
|
175 |
|
c
|
HYD019 |
Hydrocephalus Due to Congenital Stenosis of Aqueduct of Sylvius |
47 |
0.041 |
|
176 |
|
|
PRD004 |
Prediabetes Syndrome |
47 |
0.041 |
|
177 |
|
c
|
BDY019 |
Body Mass Index Quantitative Trait Locus 18 |
47 |
0.041 |
|
178 |
|
|
LYM019 |
Lymphosarcoma |
46 |
0.041 |
|
179 |
|
|
ACT113 |
Acute Myeloblastic Leukemia with Maturation |
46 |
0.041 |
|
180 |
|
|
ATN005 |
Autonomic Dysfunction |
46 |
0.041 |
|
181 |
|
|
HYP034 |
Hypertensive Encephalopathy |
46 |
0.041 |
|
182 |
|
c
|
BDY010 |
Body Mass Index Quantitative Trait Locus 4 |
46 |
0.041 |
|
183 |
|
c
|
BDY015 |
Body Mass Index Quantitative Trait Locus 12 |
46 |
0.041 |
|
184 |
|
|
GLL048 |
Glial Tumor |
45 |
0.041 |
|
185 |
|
c
|
BDY017 |
Body Mass Index Quantitative Trait Locus 14 |
45 |
0.041 |
|
186 |
|
|
URT010 |
Ureteral Obstruction |
45 |
0.041 |
|
187 |
|
|
CYN002 |
Cyanosis, Transient Neonatal |
45 |
0.041 |
|
188 |
|
c
|
BDY011 |
Body Mass Index Quantitative Trait Locus 10 |
45 |
0.041 |
|
189 |
|
|
DST006 |
Diastolic Heart Failure |
45 |
0.041 |
|
190 |
|
|
C3G002 |
C3 Glomerulopathy |
45 |
0.041 |
|
191 |
|
|
THR099 |
Third-Degree Atrioventricular Block |
45 |
0.041 |
|
192 |
|
P
|
END084 |
Endocrine System Disease |
45 |
0.041 |
|
193 |
|
P
|
PSD003 |
Pseudohypoaldosteronism |
44 |
0.041 |
|
194 |
|
c
|
PRM038 |
Primary Agammaglobulinemia |
44 |
0.041 |
|
195 |
|
|
CVD001 |
Covid-19 |
44 |
0.041 |
|
196 |
|
c
|
BDY006 |
Body Mass Index Quantitative Trait Locus 8 |
44 |
0.041 |
|
197 |
|
c
|
BDY012 |
Body Mass Index Quantitative Trait Locus 7 |
44 |
0.041 |
|
198 |
|
|
IDP033 |
Idiopathic Edema |
44 |
0.041 |
|
199 |
|
|
ELS006 |
Elsahy-Waters Syndrome |
43 |
0.041 |
|
200 |
|
|
CYT002 |
Cytokine Deficiency |
42 |
0.041 |
|
201 |
|
P
|
PRT026 |
Parotitis |
42 |
0.041 |
|
202 |
|
c
|
MYT029 |
Myotonia Congenita, Autosomal Recessive |
41 |
0.041 |
|
203 |
|
|
SPR126 |
Superior Semicircular Canal Dehiscence |
40 |
0.041 |
|
204 |
|
|
ANG049 |
Angioedema Induced by Ace Inhibitors |
40 |
0.041 |
|
205 |
|
|
HYP540 |
Hypertension, Diastolic |
40 |
0.041 |
|
206 |
|
|
OCL010 |
Ocular Hypotension |
39 |
0.041 |
|
207 |
|
c
|
HMG029 |
Hemoglobin Se Disease |
39 |
0.041 |
|
208 |
|
P
|
PRC031 |
Preeclampsia/eclampsia 1 |
38 |
0.041 |
|
209 |
|
|
HYP264 |
Hypertonia |
38 |
0.041 |
|
210 |
|
|
GLM044 |
Glomerular Disease |
37 |
0.041 |
|
211 |
|
|
MSC012 |
Muscular Dystrophy, Duchenne and Becker Type |
34 |
0.041 |
|
212 |
|
|
TRD008 |
Triiodothyronine Receptor Auxiliary Protein |
34 |
0.041 |
|
213 |
|
c
|
RNL113 |
Renal Failure, Progressive, with Hypertension |
34 |
0.041 |
|
214 |
|
c
|
CHR064 |
Chronic Monocytic Leukemia |
33 |
0.041 |
|
215 |
|
|
TXC020 |
Toxic Oil Syndrome |
33 |
0.041 |
|
216 |
|
|
VRS002 |
Virus-Associated Trichodysplasia Spinulosa |
32 |
0.041 |
|
217 |
|
|
HYP806 |
Hypertension, Early-Onset, Autosomal Dominant, with Severe Exacerbation in Pregnancy |
32 |
0.041 |
|
218 |
|
|
PPL061 |
Papular Epidermal Nevi with Skyline Basal Cell Layers Syndrome |
25 |
0.041 |
|